<http://webisa.webdatacommons.org/233866218>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/233866218>	<http://www.w3.org/ns/prov#value>	"The Aspreva Lupus Management Study (ALMS) trial comparing response rates of LN to MMF plus glucocorticoids showed similar improvement in whites, Asians, and other races (primarily African Americans and Hispanics)." .
<http://webisa.webdatacommons.org/233866218>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<guideline.gov> .
<http://webisa.webdatacommons.org/prov/198808548>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/233866218> .